NDC 70121-1237-01 - AZACITIDINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70121-1237
- Requested NDC
- 70121-1237-01
- Package NDCs from labels
- 70121-1237-1, 70121-1237-01
- Manufacturer
- Amneal Pharmaceuticals LLC
- Effective date
- 2024-08-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| AZACITIDINE - Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals LLC | 2024-08-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70121-1237-1 | AZACITIDINE | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70121-1237 | AZACITIDINE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [AMNEAL PHARMACEUTICALS LLC] | 8 | Current NDC, Legacy NDC, 1 package rows | 20240922_80a43736-0598-4e4b-85ba-e29daa290c8f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70121-1237-1 | EA - Each | 70121-1237 | 9c6d024e-2839-4022-b7fa-91202485bc1d | 1 | 2023-02-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azacitidine | AZACITIDINE | Apotex Corp | a6a5ca37-37e8-ab65-bc0b-9c0682ab52f7 | 2026-09-08 | Warnings, Adverse reactions | 485246 M801H13NRU |
| ONUREG | AZACITIDINE | Celgene Corporation | 0e95e33f-8aba-4f19-b332-2416580d358b | 2026-06-12 | Warnings, Adverse reactions | M801H13NRU |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Azacitidine | AZACITIDINE | BluePoint Laboratories. | cd9db533-8a49-4d01-99e2-b2db8db1ed38 | 2026-03-26 | Warnings, Adverse reactions | 485246 M801H13NRU |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Azacitidine | AZACITIDINE | Civica, Inc. | 2d15b3ec-ed08-48c6-a400-34e55974afad | 2025-08-25 | Warnings, Adverse reactions | 485246 M801H13NRU |
| Azacitidine | AZACITIDINE | Somerset Therapeutics LLC | 3bc4f406-2ec7-7169-e063-6394a90a81d9 | 2025-08-07 | Warnings, Adverse reactions | 485246 M801H13NRU |
| AZACITIDINE | AZACITIDINE | Armas Pharmaceuticals Inc. | 5c0a2d5f-8c34-4c04-8425-7543965cedd4 | 2025-08-05 | Warnings, Adverse reactions | 485246 M801H13NRU |
| Azacitidine | AZACITIDINE | Meitheal Pharmaceuticals Inc. | 3b96b508-046b-49ae-aefe-6d39c89a1d0e | 2025-07-21 | Warnings, Adverse reactions | 485246 M801H13NRU |
| Azacitidine | AZACITIDINE | Meitheal Pharmaceuticals Inc. | 97b0917a-03fa-4cc4-91cf-1bed57a988c9 | 2025-07-21 | Warnings, Adverse reactions | 485246 M801H13NRU |
| Azacitidine | AZACITIDINE | Fresenius Kabi USA, LLC | 3b594aba-e798-4105-b801-0b0d970747c1 | 2025-06-18 | Warnings, Adverse reactions | 485246 M801H13NRU |
| Azacitidine | AZACITIDINE | Reliance Life Sciences Private Limited | 5804d999-96eb-4fd1-b7d8-de7867c5f1d6 | 2025-05-29 | Warnings, Adverse reactions | 485246 M801H13NRU |
| Azacitidine | AZACITIDINE | BluePoint Laboratories | 5f0f9ee3-a5b1-4a25-a34c-7f38c8433f4a | 2025-05-26 | Warnings, Adverse reactions | 485246 M801H13NRU |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Azacitidine | AZACITIDINE | Camber Pharmaceuticals, Inc. | f02c9bef-e47f-4b70-95f6-9341d87346ed | 2025-04-08 | Warnings, Adverse reactions | 485246 M801H13NRU |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.